Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT05079373
NCT05079373UnknownNot Applicable

Study of Neurological Damage From Coronavirus Disease (COVID-19): Extraction of Quantitative Imaging Biomarkers for the Characterization of Pathological Profiles

University Hospital, Strasbourg, France1 site in 1 country250 target enrollmentStarted: April 1, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
250
Locations
1
Primary Endpoint
Retrospective study of the neurological damage in patients with Covid-19
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The objective of this study is to support the exploration of the NEURO-COVID-19 database and in particular to carry out the post-treatments necessary to derive quantitative information on the characterization of the lesion load, in particular with regard to of the vascular tree

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Retrospective study of the neurological damage in patients with Covid-19

Time Frame: Files analysed retrospectively from January 01, 2020 to October 31, 2021 will be examined]

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Strasbourg, France
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
An Observational Study of Neurologic Function After COVID-19 InfectionCOVID-19
NCT04564287National Institute of Neurological Disorders and Stroke (NINDS)13
Completed
Not Applicable
COVID19 Neurological ManifestationSARS-CoV 2Neurologic Manifestations
NCT04496128University of Pittsburgh300
Unknown
Not Applicable
Neurologic Manifestations of COVID-19Coronavirus Disease 2019
NCT04386083University of the Philippines1,342
Active, not recruiting
Not Applicable
Coronavirus Infection (COVID-19) and Radical Surgery in Patients With Early-stage Lung CancerSurgeryCorona Virus Infection
NCT05684549Ruijin Hospital2,000
Completed
Not Applicable
Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19COVID-19 Disease
NCT04472013University Hospital, Basel, Switzerland40